Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

TransCode Therapeutics Inc. (RNAZ) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Analysts at Zacks Research cut their Q2 2025 earnings per share estimates for shares of Exelon in a note issued to investors on Tuesday, April 1st. Zacks Research analyst R. Department now anticipates ...

Uncertainty prevailing over global macroeconomic conditions continues to be concerning for the Zacks Computer Software industry. Nonetheless, these participants are well-positioned to benefit from ...

BANGALORE, India (AP) — BANGALORE, India (AP) — Infosys Limited (INFY) on Thursday reported fiscal fourth-quarter net income of $813 million. On a per-share basis, the Bangalore, India-based company ...

It may seem hard to believe given all the focus on tariffs, inflation and the global economy, but earnings season is just around the corner. Constellation Brands, Delta Air Lines and CarMax all are ...